425: Strive & Semler Scientific Announce Merger Plans

Strive, Inc. and Semler Scientific, Inc. announced a proposed business combination, as communicated by Strive's CEO on X.com.

Summary

• Strive, Inc. and Semler Scientific, Inc. are pursuing a proposed business combination, as detailed in a communication posted on X.com by Strive's CEO.
• The communication, dated December 29, 2025, highlights the strategic and financial benefits expected from the merger.
• Strive has filed a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the transaction.
• A definitive Information Statement/Proxy Statement/Prospectus has been sent to Semler Scientific stockholders to seek their approval for the proposed transaction.

Sentiment

Score: 6

Explanation: The filing announces a significant strategic move (merger) with stated anticipated benefits, which is generally positive for growth prospects. However, it also extensively details numerous risks and uncertainties inherent in such transactions, including integration challenges, potential delays, and dilution, balancing the overall sentiment to moderately positive with caution.

Positives

• Anticipated strategic benefits from the proposed business combination.
• Expected financial benefits from the proposed business combination.
• Anticipated cost savings and strategic gains are expected to result from the transaction.

Negatives

• Potential for dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Possible adverse reactions from Strive's or Semler Scientific's customers.
• Potential changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Risk of changes in Strive's or Semler Scientific's share price before closing of the transaction.

Risks

• The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because the conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized as expected, partly due to risks associated with Bitcoin treasury strategies and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could negatively impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated, including as a result of unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate realizing strategic and financial benefits, including cost savings and strategic gains, from the proposed business combination. The successful integration and timely closing of the transaction are key expectations, though subject to various risks and uncertainties detailed in forward-looking statements.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted a communication on X.com on December 29, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The filing highlights the potential impact of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' on the combined company's future financial performance. This indicates a strategic focus on or exposure to the evolving digital asset landscape, which is a notable trend within the broader financial and technology sectors.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive face potential dilution due to the issuance of additional Class A common stock in connection with the merger.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could be subject to changes as a result of the announcement or completion of the transaction.
• Stockholders of Semler Scientific are key stakeholders whose approval is being sought for the proposed transaction.

Next Steps

• Stockholders of Semler Scientific are required to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents with the SEC concerning the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus, along with any amendments or supplements, for important information.

Key Dates

Recommendation

The proposed business combination presents potential strategic and financial benefits, but also carries significant risks, including integration challenges, potential delays, dilution for Strive shareholders, and adverse reactions from stakeholders. Given the early stage of this communication (an X.com post and a Form 425), and the extensive list of forward-looking statement risks, a 'hold' recommendation is prudent. Investors should await further detailed information from the definitive Information Statement/Proxy Statement/Prospectus and assess the full financial and operational implications before making a definitive investment decision.

Keywords

Merger, Acquisition, Business Combination, Strive Inc, Semler Scientific Inc, SEC Filing, Form 425, Corporate Governance, Bitcoin Treasury, Digital Assets